Neurophth Therapeutics Conducts Special Interview with Dr. Satoshi Kashii on World Sight Day
WUHAN, China and SAN DIEGO, Calif., Oct. 13, 2022 /PRNewswire/ -- October 13th is World Sight Day. Today, Neurophth Therapeutics, Inc. has a special interview with Dr. Satoshi Kashii, Professor of Visual Sciences and Ophthalmology, Aichi Shukutoku University, President of Asian Neuro-Ophthalmology Society, to understand his perspectives on LHON. LHON is...
Menarini Silicon Biosystems’s CELLSEARCH® CMMC and HER2-CTC Liquid Biopsy Tests obtain Reimbursement Codes with Preliminary Pricing Determination
These new codes are required to access Medicare/Medicaid insurance reimbursement for novel CELLSEARCH Circulating Multiple Myeloma Cell (CMMC) and HER2 Circulating Tumor Cell (CTC-HER2) assays, to monitor disease status in patients with life-threatening illnesses. HUNTINGDON VALLEY, Pa., Oct. 13, 2022 /PRNewswire/ -- Menarini Silicon Biosystems (MSB), Inc. is announcing that the AMA...
Galderma announces intention to expand manufacturing and innovation footprint in Asia-Pacific
Galderma, the pure-play dermatology category leader, announces its intention to explore opportunities to build its fifth manufacturing plant in Singapore Supported by the Singapore Economic Development Board, the new facility is expected to increase Galderma's manufacturing capacity by up to 350 million units per year, in response to continuing demand for premium science-based products in the Dermo‑cosmetics sector...
Harbour BioMed Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Oct. 13, 2022 /PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announced today that the Company will present new preclinical data of five portfolio assets...
Samsung Biologics obtains three global ISO certifications
Receives accreditation for information security management system, information security in cloud services, and anti-bribery management systems First global CDMO to be ISO 27001 and ISO 27017 certified Earns Excellence Award for Integrated Management System from BSI for its performance INCHEON, South Korea, Oct. 13, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization...
Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety
The Digital Therapeutic (DTx) was developed by DTx leader Alex Therapeutics using the proprietary "Alex DTx Platform" in partnership with Vicore Pharma In the study patients with Idiopathic Pulmonary Fibrosis (IPF) and anxiety were given the DTx Safety, functionality, and user experience were all studied and found positive Average reduction in anxiety, GAD-7*, was 4.2 points Pivotal phase...
Gilead and the IAS start second year of partnership to honor champions of stigma-free HIV care services in Asia and Latin America
SINGAPORE, Oct. 13, 2022 /PRNewswire/ -- Gilead Sciences, Inc. and IAS – the International AIDS Society – have renewed their Me and My Healthcare Provider partnership to expand the campaign in Brazil, Hong Kong, Mexico, South Korea and Taiwan. The collaborative partnership, now entering its second year, offers an opportunity for people...
Guiyang’s Wudang district shines in pharma sector
GUIYANG, Oct. 13, 2022 /PRNewswire/ -- A news report from chinadaily.com.cn: Southwest China's Guizhou province – one of the four main regions for traditional Chinese medicine materials production in China – has abundant medicine resources and a long history in ethnic medicine, and these days, its activities in the sector are going from strength to strength. Guiyang Xintian...
RemeGen Receives Orphan Drug Designation from FDA for Telitacicept for the Treatment of Myasthenia Gravis
YANTAI, China, Oct. 13, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation (ODD) for its proprietary novel fusion protein Telitacicept (RC18) for the treatment of myasthenia gravis (MG). Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease...
China Matters’ Feature: How is Dongguan’s new “super microscope” helping scientists dive deeper?
BEIJING, Oct. 12, 2022 /PRNewswire/ -- The Spallation Neutron Source, or SNS, in Dongguan works by using neutron beams which are able to penetrate materials with ease and provide a clear view of the inside structure. Dongguan's SNS is essentially a super microscope which allow scientists to examine materials...
